Mid-term Results of the Hancock II Valve and Carpentier-Edward Perimount Valve in the Pulmonary Portion in Congenital Heart Disease

Heart Lung and Circulation

Volumn 19, Issue 4, 2010, Pages 243-246

  Kwak, Jae Gun ^a   Lee, Jeong Ryul ^b   Kim, Woong Han ^b   Kim, Yong Jin ^b  

^a Sejong General Hospital   (South Korea)

^b Seoul National University Children's Hospital   (South Korea)

Author keywords

Congenital heart disease; Heart valve, allograft; Heart valve, prosthesis; Pulmonary valve replacement

Indexed keywords

ARTICLE; BACTERIAL ENDOCARDITIS; CARPENTIER EDWARDS BIOPROSTHESIS; CAUSE OF DEATH; CHILD; COMPARATIVE STUDY; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; HANCOCK VALVE PROSTHESIS; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE END DIASTOLIC VOLUME; HEART RIGHT VENTRICLE END SYSTOLIC VOLUME; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PULMONARY VALVE; REOPERATION; SAINT JUDE HEART VALVE PROSTHESIS; SURVIVAL RATE;

CHILD; FEMALE; HEART DEFECTS, CONGENITAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PULMONARY VALVE; PULMONARY VALVE INSUFFICIENCY; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 77949264875     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2009.10.009     Document Type: Article

References (16)

1. de Ruijter F.T.H., Weenink I., Hitchcock F.J., Meijboom E.J., and Bennink G.B.W.E. Right ventricular dysfunction and pulmonary valve replacement after correction of Tetralogy of Fallot. Ann Thorac Surg 73 (2002) 1794-1800
2. Butany J., Leong S.W., Cunningham K.S., D'Cruz G., Carmichael K., and Yau T.M. A 10-year comparison of explanted Hancock II and Carpentier-Edwards supraannular bioprostheses. Cardiovasc Pathol 16 (2007) 4-13
3. Borger M.A., Franka Nette A., Maganti M., and Feindel C.M. Carpentier-Edwards Perimount magna valve versus Medtronic Hancock II: a matched hemodynamic comparison. Ann Thorac Surg 83 (2007) 2054-2059
4. BorgerF M.A., Ivanov J., Armstrong S., Christie-Hrybinsky D., Feindel C.M., and David T.E. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis 15 (2006) 49-56
5. Roselli E.E., Smedira N.G., and Blackstone E.H. Failure modes of the Carpentier-Edwards pericardial bioprosthesis in the aortic position. J Heart Valve Dis 15 (2006) 421-428
6. Fiore A.C., Rodefeld M., Turrentine M., Vijay P., Reynolds T., Standeven J., Hill K., Bost J., Carpenter D., Tobin C., and Brown J.W. Pulmonary valve replacement: a comparison of three biological valves. Ann Thorac Surg 85 (2008) 1712-1718
7. Wright J.T.M., Eberhardt C.E., Gibbs M.L., Saul T., and Gilpin C.B. Hancock II-An improved bioprosthesis, cardiac bioprostheses. In: Cohn L.H., and Gallucci V. (Eds). Proceedings of the 2nd International Symposium (1982), Yorke Medical Books, New York 425-444
8. Bortolotti U., Milano A., Mazzaro E., Thiene G., Talenti E., and Casarotto D. Hancock II porcine bioprosthesis: excellent durability at intermediate term follow-up. J Am Coll Cardiol 24 (1994) 676-682
9. Bortolotti U., Milano A., Mossuto E., Mazzaro E., Thiene G., and Casarotto D. Porcine valve durability: a comparison between Hancock Standard and Hancock II bioprostheses. Ann Thorac Surg 60 (1995) S216-S220
10. David T.E., Armstrong S., and Sun Z. Clinical and hemodynamic assessment of the Hancock II bioprosthesis. Ann Thorac Surg 54 (1992) 661-667
11. Bottio T., Thiene G., Pettenazzo E., Ius P., Bortolotti U., Rizzoli G., Valfré C., Casarotto D., and Valente M. Hancock II bioprosthesis: a glance at the microscope in mid-long-term explants. J Thorac Cardiovasc Surg 126 (2003) 99-105
12. Schoen F.J., Harasaki H., Kim K.M., Anderson H.C., and Levy R.J. Biomaterial-associated calcification: pathology, mechanisms, and strategies for prevention. J Biomed Mater Res 22 (1988) 11-36
13. Jamieson E. Update on new tissue valves. In: Franco K.L. (Ed). Advanced therapy in cardiac surgery (2003), BC Decker, Hamilton, Ontario 177-195
14. Shen M., Kara-Mostefa A., Chen L., Daudon M., Thevenin M., Lacour B., and Carpentier A. Effect of ethanol and ether in the prevention of calcification of bioprostheses. Ann Thorac Surg 71 (2001) S413-S416
15. Cunanan C.M., Cabiling C.M., Dinh T.T., Shen S.H., Tran-Hata P., Rutledge III J.H., and Fishbein M.C. Tissue characterization and calcification potential of commercial bioprosthetic heart valves. Ann Thorac Surg 71 (2001) S417-S421
16. Duncan A.C., Boughner D., and Vesely I. Dynamic glutaraldehyde fixation of a porcine aortic valve xenograft. I. Effect of fixation conditions on the final tissue viscoelastic properties. Biomaterials 17 (1996) 1849-1856